An Australian company have made ground-breaking progress in the fight to combat the worldwide problem of sexually transmitted infections (STIs), after gaining approval for their revolutionary new type of condom.
Australian bio-tech firm Starpharma have crafted a condom lubricated
with antiviral ‘VivaGel’ which is able to destroy sexually transmitted
infections, and the condom has now been given the green light by
Australian Regulators.
The condom has been issued with a receipt
of Conformity of Assessment Certification by the Australian Therapeutic
Goods Administration (TGA) – like the CE mark certificates in Europe –
and this could now lead to a huge mass production of the product.
Starpharma are now joining forces with Australian condom maker Ansell
– the company that own an estimated 70% of Australia’s condom market –
to produce the prophylactics, which are currently being analysed by the
American Food and Drug Administration (FDA) for a potential future
release in the US.
For those who are unfamiliar with VivaGel, it is a nanotech antiviral
compound that contains 0.5% astodrimer sodium – a non-antibiotic,
antimicrobial drug that is made purposely to combat a wide range of
sexual infections such as HIV, herpes and human papilloma virus.
Dr Jackie Fairley, the chief executive of the company which created
VivaGel, said: “Condoms are not 100 per cent effective in preventing
either pregnancy or sexually transmitted infections and so anything that
you can do to reduce the number of virus particles by inactivating them
with a substance like VivaGel would reduce overall viral load.”
The condom’s TGA approval was given after the product was thoroughly
tested in accordance with certain requirements relating safety and
performance, and its release cannot come quick enough for Australians.
Genital herpes, caused by the herpes simplex virus, is caught by a
staggering one in eight Australians aged 25 and over. A good proportion
of these people are probably completely unaware they even have the virus
unfortunately as symptoms don’t always rear their ugly head. And
worryingly, without sufficient chlamydia treatment, the person can be eventually left infertile.
Statistics show that by the end of 2012, newly diagnosed HIV
infections in Australia had increased 10% over the previous 12 months,
representing the largest increase for two decades.
Peter Carroll, Ansell president and general manager of the sexual
wellness global business unit, claimed that the “ground-breaking new
sexual health” product may be on the shelves sooner rather than later.
“Ansell looks forward to rolling out its marketing and sales campaign
to support the launch of LifeStyles Dual Protect over the coming months
with the first product expected to be available on shelves soon,” he
said.
No comments:
Post a Comment